Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Recruiting1
Not yet recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

recruiting133%
not_yet_recruiting133%
completed133%

Recent Activity

1 active trials
Showing 3 of 3
completednot_applicable

Computerized Cognitive Training in MS

NCT03737825
not_yet_recruitingnot_applicable

Computerized Cognitive Rehabilitation of Patients With Cognitive Deficits Due to the Human Immunodeficiency Virus

NCT06603727
recruitingnot_applicable

Computerized Cognitive Rehabilitation of Executive Deficits in Stroke Patients

NCT05169632

Clinical Trials (3)

Showing 3 of 3 trials
NCT03737825Not Applicable

Computerized Cognitive Training in MS

Completed
NCT06603727Not Applicable

Computerized Cognitive Rehabilitation of Patients With Cognitive Deficits Due to the Human Immunodeficiency Virus

Not Yet Recruiting
NCT05169632Not Applicable

Computerized Cognitive Rehabilitation of Executive Deficits in Stroke Patients

Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3